Impel co-founder and CSO, Dr. John Hoekman, presented today at 11:00 AM on a panel discussing, "What’s New in Alzheimer’s and Other Neurodegenerative Diseases?" at Life Science Innovation Northwest 2018 in Seattle, WA. The panel was moderated by Dr. Adrian Hobden, President & CEO of CereSpir. Dr. John Hoekman was joined by Dr. Leen Kawas, President & CEO...

Impel's CEO, Jon Congleton, CSO, Dr. John Hoekman, and CMO, Dr. Stephen Shrewsbury, will be presenting at Cowen's 38th Annual Health Care Conference in Boston, MA on Wednesday, March 14th from 1:30 - 1:55 PM EDT. For more information, visit www.cowen.com/capabilities/conferences-events. ...

Impel's Co-founder and CSO, Dr. John Hoekman, will be on a panel discussion on Novel Approaches to Alzheimer’s Disease from 10:00 to 10:30 am on Wednesday, October 11 at the Neuro Advance conference in Boston. For more information, visit https://bbbiotechconference.com/conference-agenda.php?id=62...

On Thursday, June 1 at 10:00 am, John Hoekman will be presenting at the 12th annual Neurotech Investing and Partnering Conference focused on drugs, devices, and diagnostics for the brain and nervous system. He will be giving a presentation in the session focused on “Parkinson's and Movement disorders." Now in its 12th...

When: January 10, 2016 – January 11, 2016 (all-day) Where: San Francisco, CA, USA Who: Impel CEO, John Hoekman will be attending the 35th annual JPM Healthcare Conference ...